AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Ramipril; Hydrochlorothiazide in Nigeria
2 products registered with NAFDAC — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Ramicard-H 17.5 Capsules Capsule | B4-1147 | Chanrai HealthCare Limited | active | 27 Sept 2026 |
| Thiapril Tablet** Tablet | 04-7838 | May & Baker Nigeria PLC | active | 26 May 2026 |
Ramipril; Hydrochlorothiazide — NAFDAC Registration Details
NAFDAC (Nigeria) has 2 registered products containing Ramipril; Hydrochlorothiazide, of which 2 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Ramipril; Hydrochlorothiazide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.